Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 7, 2014; 20(45): 16996-17010
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.16996
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.16996
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications
Sith Siramolpiwat, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand
Author contributions: Siramolpiwat S solely contributed to this paper.
Correspondence to: Sith Siramolpiwat, MD, MSc, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand. sithsira@gmail.com
Telephone: +66-29-269793 Fax: +66-29-269793
Received: June 5, 2014
Revised: July 9, 2014
Accepted: August 13, 2014
Published online: December 7, 2014
Processing time: 188 Days and 4.6 Hours
Revised: July 9, 2014
Accepted: August 13, 2014
Published online: December 7, 2014
Processing time: 188 Days and 4.6 Hours
Core Tip
Core tip: Transjugular intrahepatic portosystemic shunts (TIPS) has been proven to be an effective treatment modality for complications related to portal hypertension (PH). Currently, several efforts are now focusing on improving its efficacy by investigating the significance of the timing of the procedure and the characteristics of patients. This article gives an overview of the TIPS procedure as well as a summary of recent evidences regarding its clinical application in the management of PH-related complications.